trending Market Intelligence /marketintelligence/en/news-insights/trending/i-vm7hzr4uyu-fu1yesiiw2 content esgSubNav
In This List

Avadel Pharmaceuticals adds director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Avadel Pharmaceuticals adds director

Avadel Pharmaceuticals plc has appointed Kevin Kotler to the board, effective Dec. 11.

Kotler is the founder and portfolio manager of Broadfin Capital LLC and a director of BioDelivery Sciences International Inc.

Dublin-based Avadel Pharmaceuticals develops and commercializes pharmaceutical products primarily for treating urology and sleep medicines.